Skip to main content

Cancer Biomarkers

Promotes research to identify, develop, and validate biological markers for early cancer detection, risk prediction, and prevention. Supports development of collaborative databases and informatics systems, advancement of new technologies, and refinement of existing technologies.

On This Page

All Heading 2s will automatically be pulled in to this list.
Do not edit the content on this template.

Major Programs

Staff List

Grid View

Photo	Name, Email, Phone	Room	Group(s)/Office
	Evans Williams, Felicia, M.B.A. felicia.evanslong@nih.gov 240-276-5076	5E636	Program Analyst \| Cancer Biomarkers
	Fu, Sidney, M.D. sidney.fu@nih.gov 240-276-6669	5E134	Program Officer \| Cancer Biomarkers
	Hodges, Nicholas, Ph.D. nick.hodges@nih.gov 240-276-7844	5E616	Program Officer \| Cancer Biomarkers
	Kohaar, Indu, Ph.D., M.Phil., M.Sc. indu.kohaar@nih.gov 240-620-0875	5E612	Program Officer \| Cancer Biomarkers
	Krueger, Karl, Ph.D. [V] karl.krueger@nih.gov		Volunteer \| Cancer Biomarkers
	Marquez, Guillermo, Ph.D. guillermo.marquez@nih.gov 240-276-7035	5E132	Program Officer \| Cancer Biomarkers
	Orr, Susan susan.orr@nih.gov 240-276-5001	5E626	Program Support Assistant \| Cancer Biomarkers
	Patriotis, Christos, Ph.D., M.Sc. christos.patriotis@nih.gov 240-276-7134	5E614	Deputy Chief \| Cancer Biomarkers
	Petruzzelli, Angie angie.petruzzelli@nih.gov 240-276-5076	5E624	Program Support Assistant \| Cancer Biomarkers
	Srivastava, Sudhir, Ph.D., M.P.H. sudhir.srivastava@nih.gov 240-276-7028	5E136	Chief \| Cancer Biomarkers
	Villanueva, Juan Miguel juan.villanueva@nih.gov	5E630	Program Analyst \| Cancer Biomarkers
	Wang, Wendy, Ph.D., M.Sc. wendy.wang@nih.gov 240-276-7117	5E566	Program Officer \| Cancer Biomarkers
	Young, Matthew, Ph.D. matthew.young@nih.gov 240-276-5846	5E610	Program Officer \| Cancer Biomarkers

Grants

PI Name Sort descending	PI Organization	Title	Grant Number	Program Official
Forsberg, Flemming	Thomas Jefferson University United States	Prostate Cancer Diagnosis by Multiparametric Ultrasound	5R01CA252311-05
Frazier, Anne Lindsay	Dana-Farber Cancer Inst United States	Assay Validation of a Circulating miRNA Test for Diagnosis and Monitoring of Malignant Germ Cell Tumors	5UH3CA240688-05	Nicholas Hodges, Ph.D.
Freedland, Stephen Jay	Cedars-Sinai Medical Center United States	Intermittent Fasting using a Fasting-Mimetic Diet to Improve Prostate Cancer Control and Metabolic Outcomes	3R01CA280081-03S1	Young Kim, Ph.D.
Friday, Bret E.B.	Essentia Institute Of Rural Health United States	Essentia Health Community Cancer Research Program - NCORP	3UG1CA189812-11S1	Vanessa A. White, M.P.H.
Furuta, Saori	Case Western Reserve University United States	Normalizing arginine metabolism with sepiaptein for immunostimulatory-shift ofHER2+ breast cancer	5R01CA248304-05
Fuschiotti, Patrizia	University Of Pittsburgh At Pittsburgh United States	Develop IL13Ra1 for diagnosis of early-stage mycosis fungoides	5R21CA280445-02	Wendy Wang, Ph.D., M.Sc.
Garcia, Jose M.	Seattle Inst For Biomedical/Clinical Res United States	SArcopenia in Men with Prostate Cancer undergoing ADT (SAP-ADT)	5R01CA279220-02	Marjorie Perloff, M.D.
Geisler, Stefanie	Washington University United States	Developing mechanism-based strategies to treat chemotherapy-induced peripheral neuropathy	5R37CA267905-04	Asad Umar, D.V.M., Ph.D.
Germain, Doris A	Icahn School Of Medicine At Mount Sinai United States	Exploring ovarian-derived hormone STC1 as the mediator of the protective effect of breast feeding against breast cancer.	5R21CA270702-02	Marjorie Perloff, M.D.
Germain, Doris A	Icahn School Of Medicine At Mount Sinai United States	Investigating the efficacy of g-Tocotrienol for the prevention of post-partum breast cancer	1R01CA301372-01	Anda Vlad, M.D., Ph.D.
Ghamande, Sharad A.	Augusta University United States	Georgia CaRes	3UG1CA189851-11S1	Brandy Heckman-Stoddard, Ph.D., M.P.H.
Ghobrial, Irene M.	Dana-Farber Cancer Inst United States	Myeloma multidimensional precancer atlas	4U01CA294507-02	Nicholas Hodges, Ph.D.
Ghobrial, Irene M.	Dana-Farber Cancer Inst United States	Molecular prediction of myeloma in African Americans	5U01CA271492-04	Claire Zhu, Ph.D.
Ghosh, Jayashri	Temple Univ Of The Commonwealth United States	Development of blood-based methylation biomarkers for CRC risk prediction	5R01CA281948-03	Matthew Young, Ph.D.
Giles, Erin	University Of Michigan At Ann Arbor United States	Obesity, body fat distribution, and breast cancer risk: is visceral fat the culprit after menopause?	5R01CA269726-02	Marjorie Perloff, M.D.